Danske Bank’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Danske Bank's NKTR Position: Q3 2026 in Review
Danske Bank held its Nektar Therapeutics (NKTR) position steady in Q3 2026 at 2 shares worth $121. The position accounts for ﹤0.01% of the portfolio, ranked #1010.
Danske Bank first reported a position in NKTR in Q2 2025 and has held it in 6 quarters since. The position peaked at $144 in Q1 2026. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Danske Bank held 2 shares of Nektar Therapeutics worth $121 as of Q3 2026.
- Danske Bank left its Nektar Therapeutics share count unchanged in Q3 2026.
- Nektar Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1010 holding.
- Danske Bank first reported a position in Nektar Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Danske Bank's Nektar Therapeutics position peaked at $144 in Q1 2026.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.